abstract: To study possible effects of assisted reproductive technologies (ART) on epigenetic reprogramming, we have analyzed the DNA methylation levels of differentially methylated regions (DMRs) of seven imprinted genes (H19, MEG3, LIT1, MEST, NESP55, PEG3 and SNRPN) as well as the promoter regions of the pluripotency gene NANOG and the tumor suppressor gene APC in chorionic villus samples (CVS) of 42 spontaneous miscarriages and stillbirths after ART and 29 abortions/stillbirths after spontaneous conception. We did not find an increased rate of faulty methylation patterns after ART, but significant and trend differences (ROC curve analysis, Wilcoxon test) in the methylation levels of LIT1 (P ¼ 0.006) and H19 (P ¼ 0.085) between ART and non-ART samples. With the possible exception of NANOG, we did not observe a gestational age effect on the methylation levels of the studied genes. The frequency of extreme methylation values in PEG3 and APC was markedly higher than in the other studied genes, indicating an increased susceptibility of some genes to epigenetic alterations. Most methylation abnormalities in CVS represented either hypermethylated DMRs of paternally and maternally imprinted genes or hypomethylated promoters of non-imprinted genes. The observed methylation abnormalities (mosaicism) are consistent with methylation reprogramming defects during early embryogenesis.
Introduction
Assisted reproductive technologies (ART) in humans have been associated with increased risks for major and minor birth defects (Hansen et al., 2005) , low birthweights (Schieve et al., 2002) and some rare imprinting disorders such as Beckwith-Wiedemann syndrome (BWS) and Angelman syndrome (AS). Several studies reported epigenetic abnormalities in ART children which could be related to the parental infertility and/or to the in vitro manipulation of gametes and embryos (Horsthemke and Ludwig, 2005; Huntriss and Picton, 2008; Grace and Sinclair, 2009) .
Epigenetic marks comprise mitotically and/or meiotically heritable modifications of DNA and/or histones that alter gene expression without affecting the DNA sequence itself (Jaenisch and Bird, 2003) . Methylation at CpG dinucleotides suppresses transcription by recruiting methylcytosine-binding proteins and chromatin remodeling complexes to cis-regulatory regions. It plays a key role in development and differentiation, in particular in genomic imprinting, X chromosome inactivation, silencing of transposons and inactivation of tumor suppressor genes. Differentiation of embryonic stem cells leads to silencing of pluripotency genes such as OCT4 and NANOG by strongly increasing their promoter methylation (Okita et al., 2007; Reik, 2007) . Methylation of a tumor suppressor gene like APC contributes to the transformation of normal somatic cells to tumor precursor cells and, subsequently, carcinogenesis (Lee et al., 2004) . Parental allele-specific methylation of cis-regulatory elements called differentially methylated regions (DMRs) during gametogenesis controls the preferential or exclusive expression of imprinted genes from one of the two parental alleles (Bartolomei and Tilghman, 1997; FergusonSmith and Surani, 2001 ).
Genome-wide reprogramming of DNA methylation occurs in two different developmental periods. The genome of primordial germ cells is completely demethylated upon their entry into the genital ridge. This results in an equivalent epigenetic state of both parental alleles. Following demethylation, the germline genomes undergo sexspecific de novo methylation including the establishment of parentspecific methylation patterns of imprinted genes (Hajkova et al., 2002) . A second wave of genome-wide demethylation and subsequent de novo methylation occurs during preimplantation development. The vast majority of male and female germline-derived methylation patterns are erased again and somatic methylation patterns are established around the time of implantation (Mayer et al., 2000; Reik et al., 2001) . Only the differential methylation patterns of imprinted genes remain unaffected by this second wave of reprogramming, ensuring their parent-specific expression and activity throughout further development (Morgan et al., 2005) . Many imprinted genes are involved in the regulation of fetal and/or placental growth and development (Reik et al., 2003) .
A large number of animal studies have suggested that ART procedures such as ovulation induction, in vitro oocyte maturation, in vitro fertilization (IVF) and intra-cytoplasmic sperm injection (ICSI) and embryo culture can interfere with methylation reprogramming during gametogenesis and/or early embryogenesis. The large offspring syndrome, which occurs in in vitro produced livestock and is somewhat reminiscent of BWS in humans, has been associated with aberrant methylation and expression of the imprinted IGF2R gene (Young et al., 2001) . Studies in the mouse model demonstrated global genome reprogramming defects in preimplantation embryos after ovulation induction and in vitro culture (Shi and Haaf, 2002; Zaitseva et al., 2007; Fernandez-Gonzalez et al., 2008) as well as aberrant methylation and/or expression patterns of imprinted genes in oocytes, embryos, fetuses and/or placentae after different ART procedures (Khosla et al., 2001; Fauque et al., 2007; Sato et al., 2007; Fortier et al., 2008; Rivera et al., 2008) . However, because of considerable species differences in epigenetic reprogramming during gametogenesis and early embryogenesis Haaf, 2006) , it is difficult to draw conclusions from animal studies to the situation in humans. Here, we analyzed the DNA methylation patterns of seven imprinted genes, one pluripotency and one tumor suppessor gene in human abortions and stillbirths, comparing ART with spontaneous conception.
Materials and Methods

Tissue samples and DNA preparation
Chorionic villus samples (CVS) of 42 spontaneous miscarriages and stillbirths after ART and 29 abortions/stillbirths after spontaneous conception from 7 to 42 weeks gestation were obtained from the Department of Paediatric Pathology, Johannes Gutenberg University Mainz, and the Department of Obstetrics and Gynecology, Hadassah University Hospital, Jerusalem. Twenty-four of the ART samples were conceived by IVF and 14 by ICSI. In four cases, it remained unclear whether IVF or ICSI had been applied. Use of 'excess' tissue materials for scientific analysis was approved by the responsible ethics committees decision no. 837.103.04 (4261) 
Methylation assays
Seven DMRs of imprinted genes (H19, MEG3, LIT1, MEST, NESP55, PEG3 and SNRPN) as well as promoters of the pluripotency gene NANOG and the tumor suppressor gene APC were analyzed by bisulfite pyrosequencing. Polymerase chain reaction (PCR) and sequencing primers (Table I) were designed using the Pyrosequencing Assay Design Software (Biotage, Uppsala, Sweden). In this context, it is noteworthy that a single-nucleotide polymorphism (rs2107425) with approximately 0.5% heterozygosity is located at the fourth base from 5 0 end of the nested reverse primer for H19. In previously published methylation analyses (El-Maarri et al., 2007) and also in our own experience this A to G change did not cause a biased amplification of DNA methylation.
Bisulfite treatment of genomic DNAs was performed with the EpiTect Bisulfite Kit (Qiagen). The PCR mixture consisted of 2.5 ml 10ÂPCR buffer, 2.5 ml 50 mM MgCl 2 , 2.5 ml 10 mM dNTP mix, 1.0 ml (100 ng) of each forward and reverse primer, 0.5 ml (2.5 U) FastStart Taq DNA polymerase (Roche Diagnostics, Mannheim, Germany), 14 ml PCR-grade water and 100 ng template DNA. PCR amplifications were carried out with an initial denaturation step at 948C for 3 min, 35 -45 cycles of 948C for 30 s, primer-specific annealing temperature for 30 s, 728C for 60 s and a final extension step at 728C for 10 min. Bisulfite pyrosequencing was performed on a PSQ96MA Pyrosequencing System (Biotage) with the PyroGold SQA reagent kit (Biotage) (Tost et al., 2003) . The Pyro Q-CpG software (Biotage) was used for data analysis.
To demonstrate the reliability of our quantitative methylation assays, we performed duplicate tests for a subset of CVS. The mean methylation difference between duplicate measurements was 1.6% for H19 (23 samples tested), 0.9% for MEG3 (22 samples), 1.9% for LIT1 (10 samples), 0.3% for MEST (1 sample), 1.2% for NESP55 (27 samples), 0.8% for PEG3 (23 samples), 0.9% for SNRPN (19 samples), 4.8% for NANOG (10 samples) and 1.0% for APC (37 samples).
Statistical analysis
Quantitative methylation data were analyzed with SPSS version 17.0.1 (http://www.spss.com). Box plots were generated using the default parameters of SPSS. They are suitable for the comparison of basic properties of different data distributions, such as location, scale and skewness. The bottom and the top of the box indicate the 25th and 75th percentile, respectively. The T bars extend from the boxes to at most 1.5 times the height of the box. Outliers are samples that do not lie within these T bars; extreme outliers have values more extreme than three times the box length away from the median. Samples falling in the T bars were considered as normally methylated, whereas extreme methylation values (outliers and extreme outliers) may indicate a methylation reprogramming defect. Fisher's exact test was used to compare the proportion of outliers between different genes.
Scatter plots were used to study possible relationships between the DNA methylation in abortions/stillbirths and the gestational age of the analyzed samples or the maternal age, respectively. A linear regression was calculated for each studied gene to infer the correlation between the dependent (methylation percentage) and the independent variable (gestational age or maternal age). Goodness of fit was assessed by the R 2 measure which can range from þ1 (perfect linear dependence) to 0 (no correlation). We plotted a receiver operating characteristics (ROC) curve for each of the nine investigated genes, comparing the methylation percentages of the ART and the non-ART groups. Using the area under curve as a test statistic for discriminative power, the corresponding P-values are exactly those obtained by a Wilcoxon rank-sum test. In addition, a multivariate discrimination analysis (Fisher's linear discriminant analysis) including the methylation data sets of the seven imprinted genes was performed. To check that each variable was approximately normally distributed, a Levene test was carried out. The non-parametric Wilcoxon test was then used to compare the methylation levels of two groups, i.e. ART versus non-ART pregnancies or single versus multiple pregnancies.
Statistical inference concerning the methylation data sets for the nine studied genes between the groups (i.e. CVS versus blood samples or abortions versus stillbirths) was done with a multivariate analysis of variance (ANOVA), which is an expanded ANOVA. t-Test was used to compare the methylation values of a particular gene between the groups. A P-value of ,5% was considered significant.
Results
Studied genes
Using bisulfite pyrosequencing, we performed quantitative methylation analysis of two paternally methylated (H19 and MEG3) and five maternally methylated (LIT1, MEST, NESP55, PEG3 and SNRPN) imprinted DMRs as well as two non-imprinted gene promoters (NANOG and APC) in CVS from 42 spontaneous miscarriages/stillbirths after ART and 29 pregnancy losses after spontaneous conception. Five of the analyzed imprinted genes represent primary DMRs (MEST, H19, LIT1, SNRPN and PEG3) that acquire gamete-specific methylation in either spermatogenesis or oogenesis and maintain their allelic methylation differences throughout development. The remaining two DMRs (MEG3 and NESP55) are secondary DMRs that are established after fertilization during early embryogenesis. Figure 1 shows representative pyrosequencing pyrograms of four CVS with DMR hypermethylation of a given imprinted gene as well as four normally methylated samples.
Imprinting of the paternally expressed IGF2 gene and the maternally expressed non-protein-coding H19 gene on chromosome 11p15 is regulated by differentially methylated CCCTC binding factor sites in the 5' region of H19 (Sasaki et al., 2000) . Methylation disturbances in the H19 germline DMR lead to dysregulation of IGF2-H19 imprinting and intrauterine growth retardation (Silver-Russell syndrome) (Gicquel et al., 2005) and overgrowth (BWS), respectively (Cooper et al., 2005) . The germline DMR within intron 10 of the KCNQ1 gene regulates expression of the paternally expressed KCNQ1OT1 (LIT1) transcript and the maternally expressed CDKN1C gene on chromosome 11p15. Epimutations in this LIT1 DMR are also associated with BWS (Mitsuya et al., 1999) . The methylation status of the germline DMR in the SNRPN promoter/exon 1 is important for imprint establishment/maintenance of genes in the Prader -Willi and AS region (Horsthemke and Buiting, 2006) . The PEG3 gene on chromosome 19q13.4 is paternally expressed in embryo and placenta and can induce apoptosis. The analyzed DMR is in the promoter region (Huang and Kim, 2009) . Another paternally expressed gene with a DMR in the promoter/exon 1 region, MEST (PEG1) is located on chromosome 7q32 and involved in the control of embryonic and placental growth (Lefebvre et al., 1998) . The maternally expressed non-coding MEG3 RNA represents a growth suppressor.
Hypomethylation of the MEG3 promoter on chromosome 14q32.2 is associated with low birthweight, muscular hypotonia, and various dysmorphisms (Zechner et al., 2009) . The GNAS locus on chromosome 20q13.3 has a highly complex imprinting pattern. Its different products (Gsalpha, XLalphas and NESP55) are involved in early postnatal adaptations and neuroendocrine functions. NESP55 is expressed from the maternal chromosome in restricted brain areas (Plagge and Kelsey, 2006) . The analyzed DMR lies in the NESP55 promoter.
The transcription factor NANOG is critical for maintaining pluripotency in mammalian cells (Chambers et al., 2003) . Early embryo cleavage stages do not contain detectable amounts of NANOG mRNA; however, in morulae and blastocyst stages, NANOG is specifically expressed in the inner cell mass and its progenitor cells, respectively. Differentiation to somatic cell lineages is associated with downregulation of NANOG. Germline mutations in the APC tumor suppressor gene cause familial adenomatous polyposis, a hereditary cancer syndrome. Somatic inactivation of APC by promoter hypermethylation is frequently seen in sporadic colorectal cancers (Esteller et al., 2000) .
Distribution of methylation values in CVS and adult blood samples
The analyzed DMRs displayed the expected differential methylation with median methylation percentages between 38% and 55% in ART and between 36% and 55% in non-ART CVS (Table II) . NANOG was hypermethylated with a median methylation of 73% in ART and 69% in non-ART samples. Consistent with the recently described maternal imprinting of APC in placenta (Guilleret et al., 2009) , the APC promoter was differentially methylated with a median methylation of 36% in ART and 35% in non-ART CVS. Figure 2A presents the results of box plot analysis of the 42 ART and 29 non-ART samples. For a given gene and abortion/stillbirth, the methylation value was considered as normal, when the average methylation percentage of all analyzed CpGs fell in the T bars of the box plot for all 71 CVS.
As a control, we performed box plot analysis of 24 adult blood samples (Fig. 2B) . With the notable exception of APC, which was hypomethylated in adult blood, as expected for a somatic tissue, blood and CVS exhibited similar median methylation values. The DMRs of imprinted genes were differentially methylated, whereas the NANOG promoter was hypermethylated. However, for all studied genes CVS showed a much broader range of methylation variation, as indicated by the length of the boxes and T bars, than adult blood samples. When we performed an ANOVA to test for differences between the methylation data sets of CVS and blood samples, the null hypothesis that there are no differences between the groups was clearly rejected (Wilks' lambda test). We found significant (t-test, P , 0.01) methylation differences for H19, MEG3, LIT1, MEST, NESP55, SNRPN, NANOG and APC, and a trend difference (P ¼ 0.07) for PEG3.
Number of extreme methylation values in ART versus non-ART CVS
The imprinted PEG3 (6 outliers) and the non-imprinted APC (7 outliers) genes exhibited significantly (Fisher's exact test; P , 0.05) more potentially abnormal methylation values (more extreme than 1.5 times the box length away from the median) in abortions/stillbirths DNA methylation in ART pregnancy losses than the other studied genes. Similarly, the 24 blood samples exhibited one outlier each in PEG3 and APC, but none in the other studied genes. Interestingly, in CVS 11 of 12 (92%) outliers in the seven studied imprinted genes represented hypermethylated DMRs, whereas all 9 (100%) outliers in the two non-imprinted genes were hypomethylated ( Fig. 2A) . Eight of the 355 (2.3%) analyzed (both imprinted and nonimprinted) methylation patterns in ART samples were outliers, that is potentially abnormal methylation values. The 238 analyzed methylation patterns of non-ART samples displayed 13 (5.5%) outliers (Table II) . When only the seven imprinted genes were considered, the ART samples exhibited 3 of 278 (1.1%) outliers. Again, the non-ART samples showed a markedly higher number of outliers, namely 9 of 190 (4.7%). The pluripotency gene NANOG was hypomethylated in 1 of 35 (3%) ART and 1 of 20 (5%) non-ART samples. The tumor suppressor gene APC was hypomethylated in 4 of 42 (10%) ART and 3 of 28 (11%) non-ART samples. Altogether, 8 of the 42 (19%) abortions/stillbirths after ART and 6 of 29 (21%) non-ART samples showed outliers in at least one of the nine studied genes (Table II) . When considering only the imprinted genes, 3 of 42 (7%) ART samples but 5 of 29 (17%) controls displayed extreme methylation values. It is interesting to note that three control samples but none of the ART samples were endowed with multiple outliers (Table III) . Most impressively, one abortion of spontaneous conception exhibited four hypermethylated DMRs. Clearly, there is no evidence for an increased rate of potentially abnormal methylation values (epimutations) in the ART group.
Methylation differences between ART and non-ART CVS
In a next step, ROC curves were calculated to test for possible differences in the methylation data sets for each of the nine studied genes between ART and non-ART CVS. This yielded significant (P ¼ 0.006) methylation differences between ART and non-ART samples for LIT1 and a trend (P ¼ 0.085) for H19 (Fig. 3) . For all other genes, no significant between-group differences were detected. A multivariate discrimination analysis based on the methylation percentages of the seven imprinted genes correctly classified 78% of the ART samples and 74% of the control samples (data not shown). This supports the assumption that the methylation values of some imprinted genes are predictive of the mode of reproduction.
Ten of 42 abortions/stillbirths in the ART group, but none of 29 pregnancy losses in the control group resulted from multiple pregnancies. When we compared single ART versus multiple ART pregnancies using the Wilcoxon test, only APC showed a significant (P ¼ 0.005) between-group difference with 35% median methylation in singlets and 38% in twins/triplets. H19 showed a trend (P ¼ 0.093) with 52% 
'$' indicates normal methylation, '#' hypomethylation and '"' hypermethylation values. Outliers are indicated by '#' or '"' and extreme outliers by '##' or '""'.
median methylation in singlets and 48% in twins/triplets. For the seven remaining genes, there were no significant methylation differences between single and multiple pregnancies. When we then compared only single pregnancies in the ART group with those in the spontaneous conception group, there was again a significant (P ¼ 0.007) difference for LIT1 between ART (50% median methylation) and control singlets (53%), but not for H19 or any other studied genes. Collectively, these data suggest that the difference in LIT1 methylation between ART and non-ART samples, as seen in the ROC curve (Fig. 3) , may be attributable to ART. In contrast, the trend toward lower H19 methylation in the ART group, compared with the non-ART group that was seen in the ROC curve may be due to the somewhat lower H19 methylation in multiple pregnancies than in single pregnancies.
Possible effects of ART procedure, gestational age and maternal age
Because some previous studies had considered ICSI as leading more frequently to medical problems than IVF (Bowen et al., 1998; Bonduelle et al., 2005) , we compared the methylation data sets of the 24 IVF and the 16 ICSI samples in our ART group. However, neither ANOVA nor ROC curve analyses showed significant methylation differences of the nine studied genes between IVF and ICSI. The gestational age of the analyzed abortions and stillbirths ranged from 7 to 42 weeks. Linear regression analyses did not reveal a significant effect of gestational age on methylation of the studied genes: R 2 was ,0.05 for H19, LIT1, MEST, PEG3, SNRPN and APC, 0.06 for MEG3 and NESP55 and 0.13 for NANOG (Fig. 4) . When we compared the methylation data sets of abortions (from 7 to 20 weeks gestation) and stillbirths (from 22 to 42 weeks gestation), only one of the nine studied genes, namely NANOG, showed a significant (t-test, P ¼ 0.01) methylation difference between the first and second half of pregnancy. Similar results were obtained when analyzing only the ART samples (P ¼ 0.003 for NANOG), whereas in the control samples none of the studied genes exhibited significant methylation differences between abortions and stillbirths.
Average maternal age in the ART and non-ART groups was 35.5 years (range 24 -48) and 31.5 years (range 20-43), respectively. Linear regression analyses did not provide evidence for a correlation between maternal age and methylation: R 2 was ,0.05 for all nine studied genes. Similar results were obtained by separate regression analyses of ART and non-ART samples. The karyotypes of most CVS were not known. Of the 25 cytogenetically examined samples, 22 had a normal and 3 an abnormal karyotype. By extrapolation, 10-15% of all analyzed samples can be expected to be aneuploid. Although we cannot exclude the formal possibility that gene dosage disturbances in the aneuploid samples could affect methylation patterns, the relatively low frequency of aneuploid samples in our study cannot explain the observed extreme methylation values in both ART and non-ART samples and the methylation differences between the groups. Similar results were obtained in all statistical tests applied here, when the three samples with known aneuploidies were excluded from analysis (data not shown). In addition, ANOVA did not reveal a significant difference between the methylation data sets of samples with normal karyotype and those with unknown karyotype.
Discussion
Because ART interferes with very sensitive periods of gametogenesis and early embryogenesis, in which the entire genome is epigenetically reprogrammed and may be particularly vulnerable to external influences, our working hypothesis was that ART might increase the risk for abnormal DMR and promoter methylation. However, unexpectedly the rate of extreme methylation values, indicative of epigenetic reprogramming defects was lower in ART-conceived abortions/stillbirths, compared with their naturally conceived counterparts. In this Figure 4 Relationship between gestational age and methylation level. The area under the curve indicates the degree of methylation difference between the ART and non-ART groups for a given gene. On average, the methylation values of H19 and LIT1 were somewhat higher in the controls than in the ART samples.
context, it is noteworthy that overall the range of methylation variation was much higher in abortions/stillbirths than in adult blood samples. Although our results cannot explain the many ART-related medical problems, it is well possible that primary epimutations leading to inappropriate DNA methylation and gene expression contribute to the high rate of pregnancy loss in humans. The studied loci represent only a small fraction of developmentally important genes. It is plausible to assume that the observed methylation abnormalities are an indicator for more profound epigenetic defects at other loci.
The vast majority of outliers in both paternally and maternally imprinted genes were hypermethylated DMRs, which may result from a failure of the up to now unknown control mechanism preventing ectopic methylation of the unmethylated allele during preimplantation development Morgan et al., 2005) . In contrast, all outliers in the two non-imprinted genes were hypomethylated promoters. Since APC and NANOG undergo methylation reprogramming after fertilization, methylation errors inherited from the gametes can be largely excluded. The observed promoter hypomethylation is rather due to faulty establishment and/or maintenance of post-zygotic methylation patterns. All observed methylation abnormalities in abortions and stillbirths point to a mosaic state that is the presence of normally and abnormally methylated cells in the same sample. Evidently, the underlying methylation errors occurred after fertilization and affect only a subset of cells. Imprinting mutations in the germline should lead to clear DMR hypomethylation (,10%) or hypermethylation (.90%) in our pyrosequencing assays.
Some genes appear to be more susceptible to extreme methylation values than others. The high number of outliers in the PEG3 DMR may at least be partially explained by its very narrow range of methylation variation, compared with most other studied genes. Evidently, PEG3 methylation is tightly regulated in CVS. The observed differential methylation of the APC promoter in most CVS is consistent with APC imprinting in human placenta (Guilleret et al., 2009) . APC hypomethylation in four ART and three non-ART samples should result in biallelic APC expression, similar to the situation in normal somatic cells. Whether or not ectopic expression of the normally methylated maternal APC allele in placenta is of disadvantage remains to be shown. The significant difference in APC methylation between singlets and twins/triplets is another indicator of methylation dynamics in CVS.
Although ART pregnancy losses were not more susceptible to methylation reprogramming defects, at least at the loci studied, the LIT1 methylation levels significantly differed between ART and non-ART samples. An interesting side aspect is the observed trend difference in H19 methylation between singlets and twins/triplets. Owing to the high number of multiple pregnancies after ART, there was also a secondary trend difference between the ART and the non-ART groups. However, in this context, it is important to emphasize that all methylation differences between the groups were within the normal range of methylation variation at the respective loci and cannot be linked to specific phenotypes/disorders. On the other hand, if ART-and naturally conceived children differ in their epigenomes, it is tempting to speculate that they may also exhibit different susceptibilities to rather unspecific and/or late-manifesting complex diseases. Epigenetic variation may not only contribute substantially to the phenotypic differences among individuals but also play an important role in the etiology of human disease (Feinberg, 2007; Hatchwell and Greally, 2007; Foley et al., 2009 ).
When interpreting the medical relevance of our data, we have to take into account that in the placental tissues studied here epigenetic gene regulation and in particular genomic imprinting seems to depend on histone modifications rather than DNA methylation (Lewis et al., 2004) . In addition, their more direct contact with the environment may make the trophectoderm and placenta much more susceptible to alterations in DNA methylation than the embryo (Fortier et al., 2008) . All these aspects may contribute to a broader range of natural methylation variation in the placenta than in the fetus and, thus, considerably hamper the identification of abnormal methylation patterns in CVS.
A recent study by Kobayashi et al. (2009) used combined bisulfite restriction analysis (COBRA) and for confirmation of abnormal methylation values classical bisulfite sequencing to compare the methylation levels of seven imprinted genes in CVS from ART and non-ART abortions. Ten of 78 (7.8%) ART and 2 of 38 (5.3%) non-ART samples displayed aberrant DMR hypomethylation, H19 being most frequently affected. Most ART samples with aberrant imprints showed similar epigenetic abnormalities, i.e. H19 or MEG3 hypomethylation, in the paternal sperm. In our study, only 1 of 12 (8%) extreme methylation values in seven studied imprinted genes was a hypomethylated DMR. These conflicting results may at least partially be explained by the fact that bisulfite pyrosequencing in our study allows more accurate quantification of methylation levels than COBRA or classical bisulfite sequencing. More likely, however, the methylation errors described in the two studies have different etiologies. While the findings of the Japanese study may be due to fertilization with abnormally hypomethylated sperm (defective imprint establishment in the germline), our data suggest an abnormal gain of methylation in the unmethylated (paternal or maternal) allele after fertilization.
Two other recent studies used peripheral blood and/or umbilical cord blood and placenta samples to compare the methylation profiles of ART and non-ART newborn children. Gomes et al. (2009) determined the LIT1 methylation status in 18 clinically normal ART and 30 non-ART newborns, using methylation-specific PCR and methylation-sensitive enzymatic digestion associated with real-time PCR. Aberrant hypomethylation was detected in three (17%) ART children but in none of the spontaneously conceived children, supporting the idea of an increased susceptibility of maternal imprints to ART-induced methylation changes. Interestingly, each of the three children with LIT1 hypomethylation had a dizygotic twin sibling with normal methylation. It was speculated that either the susceptibility to ART-induced epimutations differs between embryos or the abnormal methylation patterns arose from oocytes with germline imprinting defects. Katari et al. (2009) performed global methylation analyses of 10 ART and 13 non-ART newborn children using custom-designed methylation bead arrays. Similar to our study, only minor but significant methylation differences were observed between the groups with the ART children displaying lower average methylation levels at specific CpG sites in placenta and higher methylation levels in cord blood. Methylation differences between ART and non-ART were found in a number of known or suspected imprinted genes, including COPG2, GNAS, MEST, NNAT, SLC22A2, PEG3 and PEG10. However, it is noteworthy that overall imprinted genes did not exhibit a higher susceptibility to epigenetic alterations than non-imprinted genes. In a conceptually related study, Kanber et al. (2009) performed methylation analyses of six imprinted genes in buccal cells from 19 ICSI children born small for gestational age and from 29 term-born normal weight non-ART children. One child in the ICSI group showed hypermethylation of LIT1 and borderline hypermethylation of PEG1, most likely due to defective imprint erasure during gametogenesis of the oligozoospermic father.
At present, there are only few experimental data on the possible associations of human ART with methylation reprogramming defects. Because of the relatively small number of conceptions/children that have been studied and large differences in the study designs, no clear picture on the medical relevance of ART-induced epigenetic changes has emerged yet. Imprinting defects that can be linked to a defined syndrome(s)/disease(s) appear to be rare in human ART. One reassuring finding of our study is that the rate of extreme methylation values indicative of mosaic methylation errors is not increased in abortions and stillbirths after ART, compared with controls. Nevertheless, we found statistically significant differences in the methylation levels of some genes between ART and non-ART samples, indicating that ART or factors associated with parental infertility can affect the epigenome of the next generation. So far the role of stochastic and/or environmentally induced epimutations for human phenotypic variation and disease is likely to be largely underestimated.
